Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

Product portfolio
Potentially strong market reviews
Competitive analytics
Prospect partners
Mergers and acquisitions project data
Latest trends across a particular industry area
Research and development strategies
The analysis of new customers
A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853

Sort by:

Gonadotropin Releasing Hormone Receptor (GNRHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Gonadotropin Releasing Hormone Receptor (GNRHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Gonadotropin Releasing Hormone Receptor (...

May 2022 65 pages

GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

GPI Anchored Wall Transfer Protein 1 (PfGWT1 or EC 2.3.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY GPI Anchored Wall Transfer Prote...

May 2022 35 pages

Granulocyte Colony Stimulating Factor Receptor (CD114 or GCSFR or CSF3R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Granulocyte Colony Stimulating Factor Receptor (CD114 or GCSFR or CSF3R) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Granulocyte Colo...

May 2022 82 pages

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Granulocyte Macrophage Colony Stimulating Factor Receptor Subunit Alpha (CDw116 or CD116 or CSF2RA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Playe...

May 2022 43 pages

Growth-Differentiation Factor 15 (Macrophage Inhibitory Cytokine 1 or NSAID Regulated Gene 1 Protein or Placental Bone Morphogenetic Protein or Prostate Differentiation Factor or GDF15) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Growth-Differentiation Factor 15 (Macrophage Inhibitory Cytokine 1 or NSAID Regulated Gene 1 Protein or Placental Bone Morphogenetic Protein or Prostate Differentiation Factor or GDF15) Drugs in Devel...

May 2022 40 pages

Growth Hormone Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Growth Hormone Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Growth Hormone Deficiency Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 60 pages

Growth Hormone Receptor (Somatotropin Receptor or GHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Growth Hormone Receptor (Somatotropin Receptor or GHR) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Growth Hormone Receptor (Somatotro...

May 2022 67 pages

GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

GTPase KRas (KRas 2 or Ki Ras or c K Ras or KRAS or EC 3.6.5.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY GTPase KRas (KRas 2 or Ki...

May 2022 159 pages

Guanine Nucleotide Exchange C9orf72 (C9orf72) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Guanine Nucleotide Exchange C9orf72 (C9orf72) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Guanine Nucleotide Exchange C9orf72 (C9orf7...

May 2022 40 pages

Guanylate Cyclase (Guanylyl Cyclase or GTP Diphosphate-Lyase (Cyclizing) or GC or EC 4.6.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Guanylate Cyclase (Guanylyl Cyclase or GTP Diphosphate-Lyase (Cyclizing) or GC or EC 4.6.1.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUM...

May 2022 71 pages

Haemophilus influenzae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Haemophilus influenzae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Haemophilus influenzae Infections Drugs in Development by Stages, Target, MoA,...

May 2022 52 pages

Hantavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hantavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hantavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 40 pages

Hearing Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hearing Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hearing Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 100 pages

Heat Shock Factor Protein 1 (Heat Shock Transcription Factor 1 or HSF1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Heat Shock Factor Protein 1 (Heat Shock Transcription Factor 1 or HSF1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Heat Shock Factor...

May 2022 40 pages

Heat Shock Protein 70 (HSP70) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Heat Shock Protein 70 (HSP70) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Heat Shock Protein 70 (HSP70) Drugs in Development by Thera...

May 2022 53 pages

Heat Shock Protein 90 (HSP90) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Heat Shock Protein 90 (HSP90) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Heat Shock Protein 90 (HSP90) Drugs in Development by Thera...

May 2022 79 pages

Helicobacter Pylori Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Helicobacter Pylori Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Helicobacter Pylori Infections Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 59 pages

Hematopoietic Stem Cell Transplantation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hematopoietic Stem Cell Transplantation Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hematopoietic Stem Cell Transplantation Drugs in Development by Stages,...

May 2022 46 pages

Hemoglobin Subunit Beta (Beta Globin or Hemoglobin Beta Chain or HBB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Hemoglobin Subunit Beta (Beta Globin or Hemoglobin Beta Chain or HBB) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hemoglobin Subunit...

May 2022 47 pages

Hemoglobinopathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hemoglobinopathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemoglobinopathies Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 36 pages

Hemophagocytic Lymphohistiocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hemophagocytic Lymphohistiocytosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemophagocytic Lymphohistiocytosis Drugs in Development by Stages, Target, Mo...

May 2022 43 pages

Hemophilia A (Factor VIII Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hemophilia A (Factor VIII Deficiency) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemophilia A (Factor VIII Deficiency) Drugs in Development by Stages, Targ...

May 2022 120 pages

Hemophilia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Hemophilia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemophilia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 167 pages

Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemorrhage Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides a...

May 2022 44 pages

Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemorrhagic Fever Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 36 pages

Hemorrhagic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hemorrhagic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hemorrhagic Shock Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 46 pages

Hepacivirin (NS3-4A Protease or NS3 Serine Proteinase or EC 3.4.21.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Hepacivirin (NS3-4A Protease or NS3 Serine Proteinase or EC 3.4.21.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hepacivirin (NS3/4...

May 2022 45 pages

Hepatic Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hepatic Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatic Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 46 pages

Hepatic (Liver) Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hepatic (Liver) Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatic (Liver) Tumor Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 38 pages

Hepatitis B Virus Surface Antigen (HBsAg) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Hepatitis B Virus Surface Antigen (HBsAg) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatitis B Virus Surface Antigen (HBsAg) Drugs...

May 2022 72 pages

Hepatitis C Virus Envelope Protein E1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Hepatitis C Virus Envelope Protein E1 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatitis C Virus Envelope Protein E1 Drugs in Deve...

May 2022 36 pages

Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hepatitis E Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides...

May 2022 38 pages

Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF-SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Hepatocyte Growth Factor Receptor (Proto Oncogene c Met or Tyrosine Protein Kinase Met or HGF-SF Receptor or Scatter Factor Receptor or MET or EC 2.7.10.1) Drugs in Development by Therapy Areas and In...

May 2022 104 pages

Herpesviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Herpesviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Herpesviridae Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 328 pages

Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Herpetic Keratitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 39 pages

High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY High-Grade Glioma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 117 pages

Histamine H1 Receptor (HRH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Histamine H1 Receptor (HRH1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Histamine H1 Receptor (HRH1) Drugs in Development by Therapy...

May 2022 69 pages

Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Histamine H3 Receptor (G Protein Coupled Receptor 97 or GPCR97 or HRH3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Histamine H3 Rece...

May 2022 41 pages

Histone Acetyltransferase p300 (E1A Associated Protein p300 or EP300 or EC 2.3.1.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Histone Acetyltransferase p300 (E1A Associated Protein p300 or EP300 or EC 2.3.1.48) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Hist...

May 2022 47 pages

Histone Deacetylase (HDAC or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Histone Deacetylase (HDAC or EC 3.5.1.98) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Histone Deacetylase (HDAC or EC 3.5.1.98) Drugs...

May 2022 202 pages

Histone Lysine N Methyltransferase EZH1 (ENX2 or Enhancer Of Zeste Homolog 1 or EZH1 or EC 2.1.1.43) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Histone Lysine N Methyltransferase EZH1 (ENX2 or Enhancer Of Zeste Homolog 1 or EZH1 or EC 2.1.1.43) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Play...

May 2022 36 pages

HIV 1 Integrase (EC 2.7.7.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

HIV 1 Integrase (EC 2.7.7.) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY HIV 1 Integrase (EC 2.7.7.) Drugs in Development by Therapy A...

May 2022 47 pages

HIV 1 Retropepsin (HIV Aspartyl Protease or HIV Proteinase or Retroproteinase or Gag Protease or HIV Aspartyl Protease or EC 3.4.23.16) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

HIV 1 Retropepsin (HIV Aspartyl Protease or HIV Proteinase or Retroproteinase or Gag Protease or HIV Aspartyl Protease or EC 3.4.23.16) Drugs in Development by Therapy Areas and Indications, Stages, M...

May 2022 47 pages

Homozygous Familial Hypercholesterolemia (HoFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Homozygous Familial Hypercholesterolemia (HoFH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Homozygous Familial Hypercholesterolemia (HoFH) Drugs in Develop...

May 2022 51 pages

Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hormone Sensitive Breast Cancer Drugs in Development by Stages, Target, MoA, RoA...

May 2022 38 pages

Hormone-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hormone-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hormone-Sensitive Prostate Cancer Drugs in Development by Stages, Target, MoA,...

May 2022 59 pages

Hospital-Acquired Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Hospital-Acquired Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Hospital-Acquired Infections Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 42 pages

Human Cytomegalovirus Glycoprotein H (gH) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Human Cytomegalovirus Glycoprotein H (gH) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Human Cytomegalovirus Glycoprotein H (gH) Drugs...

May 2022 35 pages

Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Human Metapneumovirus Infections Drugs in Development by Stages, Target, MoA, R...

May 2022 46 pages

Human Papillomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Human Papillomavirus Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Human Papillomavirus Infections Drugs in Development by Stages, Target, MoA, RoA...

May 2022 131 pages